Edition:
United States

Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

198.80USD
22 May 2017
Change (% chg)

$2.21 (+1.12%)
Prev Close
$196.59
Open
$197.57
Day's High
$199.57
Day's Low
$197.33
Volume
83,437
Avg. Vol
71,171
52-wk High
$211.01
52-wk Low
$136.64

Latest Key Developments (Source: Significant Developments)

Teleflex commences phase I clinical study of RePlas freeze-dried plasma
Monday, 15 May 2017 06:30am EDT 

May 15 (Reuters) - Teleflex Inc :Teleflex (TFX) announces commencement of phase i clinical study (FDP-1) of RePlas™ freeze-dried plasma.Teleflex inc- RePlas, a lyophilized fresh frozen plasma product, being developed in collaboration with U.S. Army medical materiel development activity.  Full Article

Teleflex Q1 adjusted earnings per share $1.80 from continuing operations
Thursday, 4 May 2017 06:30am EDT 

May 4 (Reuters) - Teleflex Inc ::Teleflex reports first quarter 2017 results.Q1 adjusted earnings per share $1.80 from continuing operations.Q1 gaap earnings per share $0.87 from continuing operations.Q1 revenue $487.9 million versus I/B/E/S view $472.7 million.Q1 earnings per share view $1.69 -- Thomson Reuters I/B/E/S.Sees fy 2017 gaap earnings per share $5.59 to $5.66 from continuing operations.Teleflex - reaffirms 2017 guidance range for gaap revenue growth of 10.0 pct to 11.5 pct and constant currency revenue growth of 12.5 pct to 14.0 pct.Teleflex - raises 2017 guidance for adjusted diluted eps from a range of $8.00 to $8.15 to a range of $8.05 to $8.23.Fy2017 earnings per share view $8.10, revenue view $2.07 billion -- Thomson Reuters I/B/E/S.  Full Article

Teleflex receives FDA 510(k) clearance for Arrow AC3 Optimustm Intra-Aortic Balloon Pump
Tuesday, 2 May 2017 06:45am EDT 

May 2 (Reuters) - Teleflex Inc :Teleflex receives fda 510(k) clearance for the arrow® ac3 optimustm intra-aortic balloon pump (iabp).Teleflex receives fda 510(k) clearance for the arrow® ac3 optimustm intra-aortic balloon pump (iabp).Teleflex inc- ac3 optimus iabp will be launched at two scientific meetings in may.  Full Article

Pyng receives final order for acquisition by Teleflex
Wednesday, 29 Mar 2017 04:36pm EDT 

Pyng Medical Corp : Pyng receives final order for acquisition by Teleflex .Pyng Medical - supreme court approved plan of arrangement whereby all of issued, outstanding shares of co to be acquired by Teleflex Medical Canada Inc.  Full Article

Pyng receives securityholder approval for acquisition by Teleflex
Monday, 27 Mar 2017 09:29pm EDT 

Pyng Medical Corp :Pyng receives securityholder approval for acquisition by Teleflex.  Full Article

Teleflex announces U.S. commercial launch of spectre guidewire
Tuesday, 14 Mar 2017 06:30am EDT 

Teleflex Inc :Teleflex Inc says has announced 510(k) clearance by Food and Drug Administration and U.S. commercial launch of spectre guidewire.  Full Article

Teleflex posts Q4 EPS of $1.29 from continuing operations
Thursday, 23 Feb 2017 06:30am EST 

Teleflex Inc : Teleflex reports fourth quarter and full year 2016 results; provides 2017 guidance . Sees FY 2017 adjusted earnings per share $8.00 to $8.15 from continuing operations . Sees FY 2017 GAAP earnings per share $5.04 to $5.08 from continuing operations . Q4 adjusted earnings per share $2.13 from continuing operations . Q4 gaap earnings per share $1.29 from continuing operations . Q4 revenue $513.9 million versus I/B/E/S view $502.6 million . Q4 earnings per share view $2.09 -- Thomson Reuters I/B/E/S . Teleflex inc - company expects adjusted diluted earnings per share from continuing operations to be between $8.00 and $8.15 for full year 2017 . Teleflex inc - on a gaap basis, revenues in 2017 are expected to increase 10.0% to 11.5% over prior year . Teleflex inc - on a constant currency basis, company estimates that revenues for full year 2017 will increase 12.5% to 14.0% .FY 2017 earnings per share view $7.85, revenue view $1.91 billion -- Thomson Reuters I/B/E/S.  Full Article

Teleflex says Benson Smith to retire as CEO
Thursday, 23 Feb 2017 06:15am EST 

Teleflex Inc : Teleflex incorporated announces Benson Smith to retire as chief executive officer at end of 2017; Liam Kelly to succeed Smith as chief executive officer .Teleflex Inc - Smith will continue to serve as Teleflex's chairman of board.  Full Article

Vascular Solutions shareholders approve acquisition by Teleflex
Thursday, 16 Feb 2017 10:30am EST 

Vascular Solutions Inc : Vascular Solutions shareholders approve acquisition by Teleflex . Vascular Solutions Inc - Transaction is expected to close on February 17, 2017 .Vascular Solutions Inc- Proposal to adopt agreement and plan of merger was approved by shareholders owning approximately 99.2% of shares voted.  Full Article

Teleflex receives FDA 510(K) clearance for its Arrow VPS Rhythm(Tm) device
Tuesday, 10 Jan 2017 06:45am EST 

Teleflex Inc :Teleflex (TFX) receives FDA 510(K) clearance for its Arrow VPS rhythm(tm) device with optional tiptracker(tm) technology.  Full Article

More From Around the Web

BRIEF-Teleflex commences phase I clinical study of RePlas freeze-dried plasma

* Teleflex (TFX) announces commencement of phase i clinical study (FDP-1) of RePlas™ freeze-dried plasma